Depression Screening Policies in Chronic Care
Addressing depression in chronic care settings is vital for improving patient outcomes. Culturally relevant screening programs may optimize the identification of at-risk individuals and facilitate access to appropriate mental health services.
Berotralstat vs. Lanadelumab Safety in Angioedema Prophylaxis
For hereditary angioedema (HAE) patients, prophylactic treatment is shifting the paradigm towards a 'normal' life, but safety profiles differ significantly between oral and injectable options. Understanding these nuances is vital for tailoring treatment to individual patient needs and preferences, especially in the context of long-term management.
Systemic Sclerosis and TB What to Watch For
Patients with systemic sclerosis, already vulnerable due to immunosuppression and lung involvement, face a heightened risk of pulmonary tuberculosis. This case highlights the diagnostic and therapeutic challenges when TB mimics or masks ILD progression.
DOCK8 Deficiency and PML An Ominous Combination
Progressive multifocal leukoencephalopathy (PML) in the setting of DOCK8 deficiency underscores the critical role of cellular immunity in JC virus control. Early recognition of PML symptoms in these immunodeficient patients is paramount, as is aggressive management of JC virus reactivation.
Ketamine-Assisted Psychotherapy Protocol in Palliative Care
Patients facing end-of-life care often struggle with profound existential distress. A structured protocol for ketamine-assisted psychotherapy may offer a framework for managing this distress, though significant research gaps remain.
